Literature DB >> 15500910

Unique kinetic mechanism of Plasmodium falciparum adenylosuccinate synthetase.

Jayalakshmi Raman1, Sonali Mehrotra, Ranjith P Anand, Hemalatha Balaram.   

Abstract

Adenylosuccinate synthetase (AdSS) catalyses the Mg(2+) dependent formation of adenylosuccinate from IMP and aspartate, the reaction being driven by the hydrolysis of GTP to GDP. All characterized AdSS thus far exhibit a random kinetic mechanism. We present here kinetic evidence that unlike all other AdSS, Plasmodium falciparum AdSS (PfAdSS) has ordered substrate binding. Inhibition studies show that binding of GTP requires IMP binding while aspartate binds to the enzyme-IMP-GTP complex. A structural basis for this difference in mechanism is presented. Kinetically, PfAdSS is closer to the mouse acidic isozyme rather than to the mouse basic isozyme. The mouse acidic isozyme is thought to play a role in the purine nucleotide biosynthetic pathway. Regulation of PfAdSS in vivo can therefore, be expected to be similar to the mouse acidic isozyme, in agreement with the role of PfAdSS as the only pathway for the synthesis of adenine nucleotides in the parasite. However, PfAdSS differs from both the mammalian homologs in that fructose-1,6-bisphosphate, a potent inhibitor of the mammalian enzyme, is an activator of PfAdSS. The differences highlighted here are promising in terms of species-specific drug design, targeting this essential enzyme in the parasite.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15500910     DOI: 10.1016/j.molbiopara.2004.06.013

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  8 in total

Review 1.  Purine and pyrimidine pathways as targets in Plasmodium falciparum.

Authors:  María Belén Cassera; Yong Zhang; Keith Z Hazleton; Vern L Schramm
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

2.  Metabolic fate of fumarate, a side product of the purine salvage pathway in the intraerythrocytic stages of Plasmodium falciparum.

Authors:  Vinay Bulusu; Vijay Jayaraman; Hemalatha Balaram
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

3.  Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds.

Authors:  Gregory J Crowther; Alberto J Napuli; James H Gilligan; Kerstin Gagaring; Rachel Borboa; Carolyn Francek; Zhong Chen; Eleanor F Dagostino; Justin B Stockmyer; Yu Wang; Philip P Rodenbough; Lisa J Castaneda; David J Leibly; Janhavi Bhandari; Michael H Gelb; Achim Brinker; Ingo H Engels; Jennifer Taylor; Arnab K Chatterjee; Pascal Fantauzzi; Richard J Glynne; Wesley C Van Voorhis; Kelli L Kuhen
Journal:  Mol Biochem Parasitol       Date:  2010-09-15       Impact factor: 1.759

Review 4.  Transition-state inhibitors of purine salvage and other prospective enzyme targets in malaria.

Authors:  Rodrigo G Ducati; Hilda A Namanja-Magliano; Vern L Schramm
Journal:  Future Med Chem       Date:  2013-07       Impact factor: 3.808

5.  Structural insight into binding mode of inhibitor with SAHH of Plasmodium and human: interaction of curcumin with anti-malarial drug targets.

Authors:  Dev Bukhsh Singh; Seema Dwivedi
Journal:  J Chem Biol       Date:  2016-08-15

6.  Metabolic changes accompanying the loss of fumarate hydratase and malate-quinone oxidoreductase in the asexual blood stage of Plasmodium falciparum.

Authors:  Krithika Rajaram; Shivendra G Tewari; Anders Wallqvist; Sean T Prigge
Journal:  J Biol Chem       Date:  2022-04-06       Impact factor: 5.486

7.  Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase.

Authors:  Mamoru Niikura; Keisuke Komatsuya; Shin-Ichi Inoue; Risa Matsuda; Hiroko Asahi; Daniel Ken Inaoka; Kiyoshi Kita; Fumie Kobayashi
Journal:  Malar J       Date:  2017-06-12       Impact factor: 2.979

8.  In the quest for new targets for pathogen eradication: the adenylosuccinate synthetase from the bacterium Helicobacter pylori.

Authors:  Ante Bubić; Natalia Mrnjavac; Igor Stuparević; Marta Łyczek; Beata Wielgus-Kutrowska; Agnieszka Bzowska; Marija Luić; Ivana Leščić Ašler
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.